SHARE
Early Outcomes of a National Cancer Center s Strategy Against COVID-19 Executed Through a Disease Outbreak Response Taskforce.
January 15, 2021
We present the strategy of a comprehensive cancer center organized to make operations pandemic proof and achieve continuity of cancer care during the COVID-19 pandemic.
Disease Outbreak Response (DORS) measures implemented at our center and its satellite clinics included strict infection prevention, manpower preservation, prudent resource allocation, and adaptation of standard-of-care treatments. Critical day-to-day clinical operations, number of persons screened before entry, staff temperature monitoring, and personal protection equipment stockpile were reviewed as a dashboard at daily DORS taskforce huddles. Polymerase chain reaction swab tests performed for patients and staff who met defined criteria for testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were tracked. Descriptive statistics of out
Renowned experts challenge conventional wisdom across the imaging community
A special issue of the
Journal of the American College of Radiology (JACR), published by Elsevier, challenges conventional wisdom across the imaging community.
This collection of articles, the Provocative Issue, presents extreme opinions on pressing issues confronting radiologists with the deliberate aim of sparking positive dialog and debate that will lead to innovative solutions to improve patient care and imaging-related outcomes.
The issue is guest-edited by:
Caroline Chung, MD, MSc, Director of Advanced Imaging - Strategic Initiative and Director of Imaging Technology and Innovation, Department of Radiation Oncology and Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
Loading video.
VIDEO: JACR Deputy Editor-in-Chief Christoph I. Lee, MD, MS, and guest editor Reed A. Omary, MD, MS, discuss the JACR provocative special issue. view more
Credit: Journal of the American College of Radiology
Philadelphia, January 12, 2021 - A special issue of the
Journal of the American College of Radiology (JACR), published by Elsevier, challenges conventional wisdom across the imaging community. This collection of articles, the Provocative Issue, presents extreme opinions on pressing issues confronting radiologists with the deliberate aim of sparking positive dialog and debate that will lead to innovative solutions to improve patient care and imaging-related outcomes.
The issue is guest-edited by:
Alpha Tau Medical Announces Appointment of Peter Melnyk as New Board Member
USA - English
Share this article
Share this article
JERUSALEM, Jan. 12, 2021 /PRNewswire/ Alpha Tau Medical, the developer of breakthrough Alpha DaRT (Diffusing alpha-emitters Radiation Therapy), is pleased to announce the appointment of Peter Melnyk to its Board of Directors.
Mr. Melnyk is the CEO of Fortovia Therapeutics, a commercial stage, private equity-owned pharmaceutical company focused on oncology supportive care products. Prior to that, he held leading roles in sales, marketing, and business development in some of the top oncology franchises in the pharmaceutical and medical device industry. Recently, he was Chief Commercial Officer at Novocure, a cancer medical device company, where he built a global commercial platform and infrastructure to launch a new modality of anticancer technology based on the use of electric fields to inhibit tumor growth. He also developed business units in variou
Nationally Recognized Radiation Oncologist Joins USF Health, Tampa General Hospital
Dr. Richard Tuli joins Tampa Bay s leading academic medical center to provide comprehensive patient care and lead innovative clinical research trials.
News provided by
Share this article
TAMPA, Fla., Jan. 12, 2021 /PRNewswire/
Nationally recognized radiation oncologist and researcher Richard Tuli, MD, PhD, has joined the University of South Florida Health Morsani College of Medicine and Tampa General Hospital, where he will pursue cutting-edge treatments that offer comprehensive and personalized care to patients.
Tuli comes to Tampa from New York s Memorial Sloan Kettering Cancer Center, an internationally renowned and National Cancer Institute (NCI)-designated cancer center where he was director of Developmental Therapeutics. In Tampa, he is the chief of Radiation Oncology and vice chair of the Department of Radiology at the USF Health Morsani College of Medicine. He also is the medical di